Blackburn Kelly 4
4 · CervoMed Inc. · Filed Jan 26, 2024
Insider Transaction Report
Form 4
CervoMed Inc.CRVO
Blackburn Kelly
EVP, Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2024-01-26+16,000→ 16,000 totalExercise: $9.05Exp: 2034-01-26→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024.